Insilico's AI-designed drug Rentosertib reverses biological age by 3-4 years in 12-week trial
AllThingsApx · x · 2026-09-07
Insilico Medicine reports that Rentosertib, an AI-designed drug candidate originally developed for a rare lung condition, appears to reverse biological aging in humans.
- After 12 weeks, all 6 aging clocks run by 6 independent groups read subjects 3-4 years younger
- It is claimed to be the first clinical demonstration of biological age reversal by an AI-designed drug
- Insilico invites users to run their own experiments with its SOTA models
More from Research
- scikit-learn 1.9 ships metric_at_thresholds to simplify optimal decision threshold search — GaelVaroquaux · 2026-09-08
- Astra agent inside Codex picks the same cancer sequencing variants a researcher would choose — iskander · 2026-09-08
- Enterprise agent evals need world-first design, not task-first, argues Shahules Anwar — Shahules786 · 2026-09-08
- Ineffable Labs adds six co-founders alongside ex-DeepMind's David Silver — giffmana · 2026-09-08
- Training a 9B model with GRPO to build low-poly Blender rooms: lessons learned — TheMoonMidas · 2026-09-08
- 2026 PNPL competition targets non-invasive speech decoding with MEG — pnpl · 2026-09-08